![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
Richard Furman, MD
Leukemia Specialist
Specialities: Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia
Spoken languages: English
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
more_vert
-min_30b108db-ffda-4f68-a776-427bed864ef4.jpg?alt=media&token=7fae0fe4-f10f-4e19-92af-f98b9353e954)
Clinical Expertise
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
About
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
Location
Weill Cornell Medical Center: 425 E 61st St 8th floor, New York, NY 10065, USA
Get the Latest Chronic Lymphocytic Leukemia Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.